Pain Management Associated with Total Joint Arthroplasty: A Primer

Pain Management Associated with  Total Joint Arthroplasty: A Primer


Michelle J Lespasio, DNP, JD, ANP1; AJ Guarino, PhD2;
Nipun Sodhi3; Michael A Mont, MD3

Perm J 2019;23:18-169 [Full Citation]
E-pub: 03/28/2019

Pain Management Associated with  Total Joint Arthroplasty: A Primer


This primer presents a synopsis of pain management strategies associated with total joint arthroplasty. Patients considering total joint arthroplasty often experience moderate to severe pain, which places them at risk of opioid abuse or addiction. Currently, the best practice strategies involve the development of individualized multimodal perioperative approaches to pain management. These practices include prescribing opioids at their lowest dose and for the shortest duration necessary to control symptoms, with close monitoring of common adverse effects. Implementing these practices is essential to battling the ongoing opioid crisis in the US.


The intent of this article is to deliver a concise introduction to pain management in total joint arthroplasty (TJA) in the midst of the ongoing opioid crisis in the US. The goals are to provide the reader with a synopsis of the current understanding of the opioid crisis and discuss its implications for pain management in patients with end-stage osteoarthritis who undergo TJA, most notably total knee arthroplasty (TKA) and/or total hip arthroplasty (THA). The effects of opiate pain management education on clinical outcomes and patient satisfaction are also described. Please see the Sidebar: Advance Organizer Quiz to Retrieve, Use, and Organize the Materials Presented.

Pain Management Associated with  Total Joint Arthroplasty: A Primer


The US is experiencing the worst overdose epidemic in history, with prescription drug abuse as the leading cause of accidental death.1 In 2015 alone, there were 52,404 lethal drug overdoses, of which almost 40% were related to legal prescription pain relievers.2 Between 1999 and 2010, there was a 340% increase in prescription opioid-related fatalities.3 The Centers for Disease Control and Prevention (CDC) has designated opioid overdose prevention as one of the leading public health issues that requires prompt attention by the medical community and public.2 

According to the CDC, a major cause of the overdose epidemic is that opioids (eg, oxycodone, hydrocodone, and methadone) are overprescribed.1 In 2012, there were 259 million opioid prescriptions—as many prescriptions as there were adults in the US at that time. In 2016, more than 66 opioid prescriptions were issued for every 100 people.4 While controversial, it has been reported that although the US makes up less than 5% of the global population, it consumes nearly 80% of the global opioid supply.5,6 A spiraling increase in opioid prescriptions in the US is believed to be the most important factor leading to lethal opioid drug overdoses. Studies document that the opioid crisis primarily originates from the misuse of opioid prescriptions.7 Opioid prescriptions, obtained either directly from or indirectly through prescribers, are linked to long-term opioid therapy and a major risk of opioid misuse and addiction.7

The proportion of elderly patients being prescribed opioids at least once for management of osteoarthritis increased from 31% in 2003 to 40% in 2009.8 Although osteoarthritis is frequently considered to be a disease of the elderly, the median age at diagnosis of knee osteoarthritis is 55 years, leaving a considerable number of years for patients to live with osteoarthritis and to have the potential to become addicted to prescription opioids.7 In some patients undergoing TJA, postoperative pain management with opioids may serve as a trigger for long-term opioid use and addiction.9,10 

In the face of serious risks and the absence of evidence concerning the long-term effectiveness of prescription opioids, there was a dramatic increase before 2013 in the acceptance and use of prescription opioids for surgical pain management.1 Noteworthy is that despite the increase in use of prescription opioids, there has not been a corresponding change in pain reduction reported by Americans.1 Now, however, there is close scrutiny in the US on prescribing opioids to patients because of the adverse consequences associated with long-term use and dependence.


Opioids are drugs that interact with specific receptors in the central nervous system to relieve pain.11 Beyond their direct mechanism of action to control pain, opioids are also known to activate the reward pathway by producing a euphoric sensation that helps patients overcome pain.4 It is this euphoria that addicted individuals seek.12,13 Opiates are a subclass of opioids and include the commonly abused drugs morphine, codeine, and oxycodone.14 


According to the American Psychiatric Association, addiction is a complex condition, a brain disease that is manifested by compulsive substance use despite harmful consequence.15 People with addiction (severe substance use disorder) have an intense focus on using a certain substance or substances, such as alcohol or drugs, to the point that it takes over their lives.16 They keep using alcohol or a drug even when they know it will cause problems.15


Symptoms of opioid addiction include intense urges for the drug, taking increasing amounts of the drug, and stealing or illegally obtaining opioids not prescribed. To address the potential for addiction with opioid use, the CDC has recommended preventive approaches for use by clinicians when prescribing opioids to patients. Because the risk of long-term opioid use increases with each additional day the drug is supplied,15 one approach to reduce the risk of dependence and addiction is by limiting the supply of prescription opioids. This notion of limiting prescription opioids is supported by the CDC, which reported that the risk of long-term opioid use increased 125% between patients with at least 1 day of opioid therapy and those with more than 8 days.1,17

Opioid Withdrawal

Once a patient ceases taking opioid medication, s/he may experience unpleasant withdrawal symptoms (see Sidebar: Common Symptoms of Opioid Withdrawal),14 causing his/her return to opioid medication to avoid the withdrawal symptoms. As a result, addiction may develop.

Pain Management Associated with  Total Joint Arthroplasty: A Primer

Risk Factors for Misuse of Prescription Opioids

Certain factors increase the risk of the misuse of prescription opioids leading to persistent use. Persistent opioid use is defined as having any number of opioid prescriptions or dosing at least 90 days continuously, or use of opioid prescriptions for 120 nonconsecutive days.18 Examples of certain factors that increase the risk of persistent use are the patient’s sex and age.19 Women may become dependent on prescription pain relievers more quickly than men because women are more likely to have chronic pain, be prescribed prescription pain relievers, be given higher doses, and use them for a longer period of time than do men.20 It is estimated that between 1999 and 2010, approximately 48,000 women died of prescription pain reliever overdoses.20 The CDC reported in 2015 that approximately 276,000 adolescents (12-17 years old) were current nonmedical users of pain relievers, with 122,000 having an addiction to prescription pain relievers.17 Although the prescriptions for opioids among adolescents and young adults has nearly doubled from 1994 to 2007, most adolescent addicts receive their drugs from friends or relatives.17 There is some evidence that younger patients, particularly teenagers ages 15 to 19 years, but even as early as 13 years, and young adults in their early twenties, are at a higher risk of persistent opioid use in the general surgical population21 and that younger patients in their teens use higher opioid amounts perioperatively.22

Among surgical patients, female sex; age older than 50 years; and preoperative history of drug abuse, alcohol abuse, depression, benzodiazepine use, or antidepressant use are associated with chronic opioid use.23 In one study, being female was associated with a 40% higher risk of long-term opioid use after surgery, and specifically after THA surgery.19 

Patients, including elderly individuals, who are prescribed opioids recommended for treatment of osteoarthritis before TJA, are at increased risk of exposure to opioids for a longer time.18 Elderly patients often experience other adverse effects from taking opioids, including dizziness and sedation, which increases their risks of falls and fractures.24 

Use of opioids persistently for 4 months or longer before TJA is a strong predictor of persistent use of opioids after the surgery.25 Patients known to be taking opioids for other comorbid painful conditions, including back pain and diabetes mellitus, are more likely to be exposed to opioids for longer periods, increasing their chance of experiencing potentially dangerous opioid-related adverse effects.19 One such adverse effect includes the development of tolerance to an opioid which refers to a decreased response from the drug at the same dosage previously prescribed.26 Another adverse effect to long-term opioid use is hyperalgesia, which is an abnormally heightened sensitivity to pain.26 Patients with depression and preoperative use of hypnotic agents are at increased risk of persistently using opioids after surgery.19 Similarly, patients subject to postoperative surgical management with opioids increase their potential for long-term use of opioids, increasing their chance of developing opioid-related adverse effects, including tolerance and hyperalgesia.19,27 

Patients with end-stage osteoarthritis of the knee and hip who are awaiting TJA are in their own category of increased risk of opioid overprescription24 and present their own risks for misuse. This occurs primarily because of the nature of severe pain experienced by patients with end-stage osteoarthritis and the perceived lack of efficacy of nonpharmacologic and other pharmacologic interventions in alleviating pain, improving function, and/or providing a sustainable quality of life. This perceived lack of efficacy of other therapeutic options is believed to account for the use of opioid prescriptions.24 Studies show, however, that opioids offer limited benefit for management of osteoarthritis pain and are generally not advised.27 It is recommended that opioid prescription, if necessary, be considered only for short-term use (less than a week) in patients with severe pain awaiting TJA. The potential for serious adverse effects, including the potential for drug misuse, abuse, addiction, and withdrawal symptoms, outweigh the perceived advantages of long-term use of opioids.26 Most prescribers of opioids for patients before and after TJA are not orthopedic physicians.28 Therefore, coordination of prescription opioids among health care practitioners is essential to improve narcotic pain management in patients with osteoarthritis undergoing TJA.28 

Identification of risk factors that contribute to suboptimal clinical outcomes (including pain relief and successful restoration of joint function) after TJA is essential to achieve the objectives of eliminating the opioid crisis.29,30 For some patients, pain relief after TJA is suboptimal, and their pain can be challenging to manage. Prolonged use of opioid pain medication in this group of patients has been found to be ineffective and to increase their risk of long-term opioid use. According to 1 study, approximately 20% of patients undergoing TKA and about 10% of patients undergoing THA reported persistent or recurrent pain in the year after the surgery.31,32 Another study investigated the relationship of prolonged use of opioid medication as a possible indicator of early THA failure.33 Results indicated that persistent postoperative use of opioids from 3 months to 1 year after surgery was associated with higher risk of revision THA and may be an early indicator of potential THA surgical failures.33,34


When nonsurgical treatment options fail, surgical options, such as TJA, may be the only feasible alternative to manage a patient’s moderate to severe pain. The objectives for performing TJA are to correct a deformity and/or restore function to an affected joint, and for many patients, to relieve substantial pain commonly derived from osteoarthritis, a substantial influencing factor associated with TJA.29 TJA can be performed just about anywhere on the body where there is a joint. Before the surgical option of TJA is considered, nonsurgical interventions, including physical therapy, corticosteroid injections, and nonopioid pain medication, are preferred and often required for pain management associated with joint pain and dysfunction. In conjunction with physical therapy and corticosteroid injections (which can be done in the office setting), nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen in safe doses are the preferred agents of choice.35 Use of proton-pump inhibitors to counteract the effects of gastrointestinal ulcer disease and bleeding associated with NSAIDs is recommended.

Prescription opioids (eg, morphine, codeine, and oxycodone) for patients with chronic joint pain and dysfunction with end-stage osteoarthritis who are awaiting TJA show restricted gains and are not encouraged.14 Observational studies have demonstrated that for patients planning to undergo total joint replacement, those receiving opioids preoperatively experience less pain relief until several years after surgery compared with those who did not use opioids preoperatively.36 In addition, preoperative use of opioids independently predicted opioid requirement postoperatively and is associated with prolonged hospital stay, greater risks of inpatient hospital complications, and early revision surgery.36-38 Thus, the rate of successful pain management among patients after TJA is unpredictable, and preoperative use of opioids may be a modifiable risk factor for poor outcomes.24 

There is evidence suggesting that patients undergoing TKA are more likely to require opioid refills than those undergoing THA.30 One review showed that the patients undergoing TKA were twice as likely to require refills of opioid prescriptions and were prescribed a greater total morphine equivalent dose for a longer time postoperatively.30 Additionally, TKA patients with a comorbidity or who were being treated for anxiety or depression were more likely to require a refill.30 

Mechanism of Postoperative Pain

Postoperative pain results from inflammation caused by tissue trauma (ie, surgical incision, dissection, burns) or direct nerve injury (ie, nerve transection, stretching, or compression). The patient senses pain through the afferent pain pathway, which is the target of various pharmacologic agents.7 Use of direct numbing agents (eg, lidocaine) or drugs that diminish the local hormonal response to injury (NSAIDs, such as aspirin or ibuprofen) can be used to block pain receptor activity, thereby decreasing pain receptor activation.10 

Factors to Consider in Postoperative Pain Management

A primary goal of pain management associated with TJA is patient comfort with a smooth transition from hospital care to home. When formulating a plan for postoperative pain control, use of regional or local analgesic techniques for certain procedures (ie, nerve blocks, patient-controlled analgesia pumps) or having patients take preoperative oral pain medication is recommended before a procedure. In addition, consideration of individual patient factors, such as age, history of long-term opioid use, and comorbidities, may affect the choice of analgesic options.32,39 Elderly patients may be more sensitive to the effects of opioid pain medication, and the type of medication and doses should be adjusted accordingly. Patients with long-term use of opioids may require a varied and multimodal approach for optimization of postoperative pain control. Those in whom tolerance to opioids has developed may show no acute effects after use of the drug at a dose typical for that patient but may show signs of opioid withdrawal after surgery.14 Patients with obstructive sleep apnea may be more prone to adverse effects of sedatives and opioids, requiring either dose modification or avoidance of these medications.10,40 Therefore, specific individualized approaches to optimal opioid prescribing should be carefully planned preoperatively for patients requiring postoperative pain medication.

Goals of Postoperative Pain Management in Total Joint Arthroplasty

Goals of postoperative acute pain management in patients undergoing TJA include relief of pain and suffering, achieving early mobilization postoperatively, reducing hospital length of stay, and achieving patient satisfaction. Prescription opioids should be prescribed at the lowest dose and shortest duration necessary to control symptoms, and close monitoring of adverse effects is advised. Use of prescription opioids should be avoided or limited whenever possible, especially in older adult and elderly populations, or in patients with a prior history of opioid abuse.11,40 Mild to moderate pain can be expected in patients after TJA. Because of this expected pain, patients who undergo TJA generally require a prescription for higher-dose opiate pain medication for several days after surgery. Current practices recommend an opioid taper plan on hospital discharge (Table 1) and open communication with patients undergoing TJA. At one academic medical center, a specific goal is to ensure that all opioid prescriptions at the point of discharge on the surgical services meet best practice. Best practice is defined as prescribing less than 90 morphine milligram equivalents per day, to specify the total number of days of the prescription, and not to exceed 7 days unless there is clinical justification for an extended course within the patient’s medical chart (Eric L Smith, MD, personal communication, 2018 Oct 16).a


Prescribing opioids for acute pain is associated with a greater likelihood of long-term opioid use,41 and a greater amount of initial opioid exposure (ie, greater higher total dose) is associated with higher risks of both long-term use and overdose.41 Thus, opioids should be prescribed only when necessary, at the lowest effective dose, and for the shortest duration necessary. To help monitor opioid use and potentially prevent overprescribing, prescription-monitoring programs available in the US and other countries can be used to identify patients prescribed opioid medications by multiple practitioners. In fact, regulations in some US states require clinicians to review this online resource before starting an opioid prescription for a patient.42 It is important to keep in mind when prescribing opioid medication that no single or simple change in prescribing behavior can be expected to alleviate all risks while properly managing pain.43

It is important to evaluate patients for tolerance to opioid pain medication before prescribing the drug.14 Tolerance, the decreased response from a drug at the same dosage previously prescribed, can be concerning because patients then need to use a greater amount of the drug to receive the same therapeutic effect.14 As mentioned earlier, by taking increased doses, especially for longer durations, patients are at a greater risk of addiction, medication adverse effects, or even death caused by overdose. In assessing for tolerance, physicians should ask patients whether they have been using increasing doses of pain medication to get the same effect. If so, a tolerance has likely developed, and that patient is more likely to experience withdrawal symptoms if s/he abruptly stops using the opioid. Patients who have recently consumed an opioid and are tolerant to its effects may not show obvious signs of intoxication or withdrawal. Any patient in whom opioid tolerance is identified before surgery should receive a specific plan for postoperative pain management and be followed-up closely after surgery by his/her primary care practitioner and/or a pain management specialist.

Pain control regimens should be designed to meet the needs of each individual patient, taking into account the patient’s age; medical, psychological, and physical conditions; levels of fear or anxiety; personal preference regarding undergoing surgery; and tolerance and response to therapeutic agents.

The optimal strategy for postoperative pain control consists of identifying the risk factors for persistent opiate use among patients and using these indicators to stratify risk preoperatively. This approach to pain management can help target patient groups for multimodal therapy to minimize the needs for opioid pain medication.10 Clinicians should develop an individualized approach to pain management for patients undergoing TJA. Use of both nonopioid and opioid medications to target central mechanisms involved in the perception of pain, each acting at different sites of the pain pathway, may reduce a patient’s dependence on a single medication and, more importantly, may reduce or eliminate the need for opioids.10,14 Synergy between opioid and nonopioid medications reduces both the overall opioid dose and unwanted opioid-related adverse effects.

Pain Management Associated with  Total Joint Arthroplasty: A Primer


The general approach for effective perioperative pain management involves prescribing opioids only when necessary, at the lowest effective dose, and for the shortest duration necessary.17 With attention across the country now on the opioid crisis, judicious safe prescribing practices are actively advocated and required to avoid risks of opiate overuse and overdose and to help prevent opioid-related tragedies.

The general approach recommended for effective postoperative pain control in TJA starts early in the surgical process and involves an individualized multimodal approach to patient care. Risk stratification and identification of risk factors for persistent use are advised. Reducing the dependence on a single opioid medication and targeting central mechanisms involved in the perception of pain can minimize the use of opioids and avoid overuse. Coordination of opioid prescriptions among health care practitioners is recommended, as is improved communication with patients on expectations of narcotic use both preoperatively and postoperatively. Strategies to assess the risk of overuse and overdose before prescribing opioids are advised. One strategy is to use statewide electronic prescription drug monitoring programs that allow clinicians to identify patients prescribed opioid medications by multiple practitioners. Being cognizant of the signs and symptoms of dependence, tolerance, addiction, and overdose is essential knowledge before the implementation of any surgical pain management plan. Prevention through avoidance of overprescription of opiate medication is key to solving the opioid crisis.

a Personal communication: Eric L Smith, MD, Chief, Division of Arthroplasty, Associate Professor of Orthopaedic Surgery. Opioid Prescribing for Acute Pain. Boston Medical Center, Boston, MA, October 16, 2018, unpublished data.

Disclosure Statement

Dr Mont receives funding from American Academy of Orthopaedic Surgeons, Rosemong, IL; CyMedica Orthopedics, Scottsdale, AZ; DJ Orthopaedics, Dallas, TX; Johnson & Johnson, New Brunswick, NJ; Microport, Shanghai, China; National Institutes of Health: National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD; National Institutes of Health: National Institute of Child Health and Human Development, Rockville, MD; Ongoing Care Solutions, Pinellas, FL; Orthosensor, Dania Beach, FL; Pacira Pharmaceuticals, Parsippany, NY; Peerwell, San Francisco, CA; Performance Dynamics Inc, Muncie, IN; Stryker, Kalamazoo, MI; Surgical Technologies, St Paul, MN. Dr Mont is the Assistant Editor in Chief of the Journal of Arthroplasty and on the Editorial Board of the Journal of Knee Surgery and Orthopedics.

The other author(s) have no conflicts of interest to disclose.


Kathleen Louden, ELS, of Louden Health Communications performed a primary copy edit.

How to Cite this Article

Lespasio MJ, Guarino AJ, Sodhi N, Mont MA. Pain management associated with total joint arthroplasty: A primer. Perm J 2019;23:18-169. DOI:

Author Affiliations

1 Boston Medical Center, MA

2 The Fullbright Specialist Program, Washington, DC

3 Lenox Hill Hospital, Northwell Health, New York, NY

Corresponding Author

Michelle J Lespasio, DNP, JD, ANP (

1. Paulozzi LJ, Mack KA, Hockenberry JM; Division of Unintentional Injury Prevention, National Center for Injury Prevention and Control, CDC. Vital signs: Variation among states in prescribing of opioid pain relievers and benzodiazepines—United States,
2012. MMWR Morb Mortal Wkly Rep 2014 Jul 4;
 2. 2018 Annual surveillance report of drug-related risks and outcomes—United States. Surveillance special report 2 [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; 2018 Aug 31 [cited 2018 Nov 8]. Available from:
 3. Kilaru AS, Gadsden SM, Perrone J, Paciotti B, Barg FK, Meisel ZF. How do physicians adopt and apply opioid prescription guidelines in the emergency department? A qualitative study. Ann Emerg Med 2014 Nov;64(5):482-9.e1. DOI:
 4. Mattson C, Scheiber L Scholl L, et al. Annual surveillance report of drug-related risks and outcomes—United States, 2017 [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; 2017 [cited 2018 Jul 15]. Available from:
 5. Report of the International Narcotics Control Board for 2008 [Internet]. Vienna, Austria: International Narcotics Control Board report; 2009 Feb 19 [cited 2019 Jan 16]. Available from:
 6. Chriss R. It’s a myth America consumes 80% of the world’s opioids. La Crescenta, CA: Pain News Network. 2018 Mar 8 [2019 Jan 16]. Available from:
 7. Nowak L. America’s pain points [Internet]. St Louis, MO: Express Scripts; 2014 Dec 9 [cited 2018 Aug 18]. Available from:
 8. Wright EA, Katz JN, Abrams S, Solomon DH, Losina E. Trends in prescription of opioids from 2003-2009 in persons with knee osteoarthritis. Arthritis Care Res (Hoboken) 2014;66(10):1489-95. DOI:
 9. Losina E, Weinstein AM, Reichmann WM, et al. Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US. Arthritis Care Res (Hoboken) 2013 May;65(5):703-11. DOI:
 10. Mariano E. Management of acute perioperative pain [Internet]. Alphen aan den Rijn, Netherlands; updated 2018 Aug 10 [cited 2018 Nov 15]. Available from:
 11. How Drugs Affect the Brain and Central Nervous System [Internet]. Brentwood, TN: American Addiction Centers; 2018 Nov 14 [cited 2018 Nov 15]. Available from:
 12. Mudumbai SC, Oliva EM, Lewis ET, et al. Time-to-cessation of postoperative opioids: A population-level analysis of the Veterans Affairs Health Care System. Pain Med 2016 Sep 1;17(9):1732-43. DOI:
 13. McCleane G, Smith HS. Opioids for persistent noncancer pain. Anesthesiol Clin 2007 Dec;25(4):787-807. DOI:
 14. Case-Lo, C. Withdrawing from opiates and opioids: What are the symptoms of opioid withdrawal? [Internet]. New York, NY: Healthline Newsletter; 2005-2018 [cited 2018 Nov 15]. Available from:
 15. What is addiction? [Internet]. Washington, DC: American Psychiatric Association; c2018 [cited 2018 Aug 20]. Available from:
 16. SCOPE of pain: Safe and competent opioid prescribing education [Internet]. Boston, MA: Boston University School of Medicine; c2018 [cited 2018 Aug 20]. Available from:
 17. Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use—United States, 2006-2015. MMWR Morb Mortal Wkly Rep 2017 Mar 17;66(10):265-9. DOI:
 18. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA 2016 Apr 19;315(15):1624-45. DOI:
 19. Von Korff M, Saunders K, Thomas Ray G, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain 2008 Jul-Aug;24(6):521-7. DOI:
 20. Inacio MC, Hansen C, Pratt NL, Graves SE, Roughead EE. Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: A retrospective cohort study. BMJ Open 2016 Apr 29;6(4):e010664. DOI:
 21. Prescription painkiller overdoses: A growing epidemic, especially among women [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; 2018 Sep 4 [cited 2018 Aug 20]. Available from:
 22. Oakes K. Persistent opioid use a risk after surgery in teens and young adults. The Hospitalist 2018; 1-4.
 23. Petre B, Roxbury CR, McCallum JR, Defontes KW 3rd, Belkoff SM, Mears SC. Pain reporting, opiate dosing, and the adverse effects of opiates after hip or knee replacement in patients 60 years old or older. Geriatr Orthop Surg Rehabil 2012 Mar;3(1):3-7. DOI:
 24. Sun EC, Darnall BD, Baker LC, Mackey S. Incidence of and risk factors for chronic opioid use among opioid-naïve patients in the postoperative period. JAMA Intern Med 2016 Sep 1;176(9):1286-93. DOI:
 25. Deveza LA, Hunter DJ, Van Spil WE. Too much opioid, too much harm. Osteoarthritis Cartilage 2018 Mar;26(3):293-5. DOI:
 26. DePen A, Shen D, Ersek M. Mechanisms of opioid-induced tolerance and hyperalgesia. Pain Manag Nurs 2007 Sep;8(3):113-21. DOI:
 27. Kim SC, Choudhry N, Franklin JM, et al. Patterns and predictors of persistent opioid use following hip or knee arthroplasty. Osteoarthritis Cartilage 2017 Sep;25(9):1399-406. DOI:
 28. da Costa BR, Nüesch E, Kasteler R, et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2014 Sep 17;(9):CD003115. DOI:
 29. Namba RS, Paxton EW, Inacio MC. Opioid prescribers to total joint arthroplasty patients before and after surgery: The majority are not orthopedists. J Arthoplasty 2018 Oct;33(10):3118-24.e3. DOI:
 30. Bedair H. Opioid prescription refills more common after TKA than THA [Internet]. Boston, MA: Massachusetts General Hospital Advances in Motion; 2018 Feb 18 [cited 2018 Nov 15]. Available from:
 31. Dwyer MK, Tumpowsky CM, Hiltz NL, Lee J, Healy WL, Bedair HS. Characterization of post-operative opioid use following total joint arthroplasty. J Arthroplasty 2018 Mar;33(3):668-72. DOI:
 32. Pinto PR, McIntyre T, Ferrero R, Araújo-Soares V, Almeida A. Persistent pain after total knee or hip arthroplasty: Differential study of prevalence, nature, and impact. J Pain Res 2013 Sep 11;6:691-703. DOI:
 33. Namba R, Inacio M, Pratt N, et al. Postoperative opioid use as an early indication of total hip arthroplasty failure. Acta Orthop 2016; 87(Suppl 1):37-43. DOI:
 34. Beswick AD, Wylde V, Gooberman-Hill R, Blom A, Dieppe P. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open 2012 Feb 22;2(1):e000435. DOI:
 35 Osteoarthritis [Internet]. North Shore, Auckland, New Zealand:; 2000-2018 [cited 2018 Nov 15]. Available from:
 36. Inacio MC, Pratt NL, Roughead EE, Paxton EW, Graves SE. Opioid use after total hip arthroplasty surgery is associated with revision surgery. BMC Musculoskelet Disord 2016 Mar 10;17:122. DOI:
 37. Reinberg S. Opioid dependence can start in just a few days [Internet]. Norwalk, CT: HealthDay; 2017 Mar 16 [cited 2018 Nov 15]. Available from:
 38. Zywiel MG, Stroh DA, Lee SY, Bonutti PM, Mont MA. Chronic opioid use prior to total knee arthroplasty. J Bone Joint Surg Am 2011 Nov 2;93(21):1988-93. DOI:
 39. Rozell JC, Courtney PM, Dattilo JR, Wu CH, Lee GC. Preoperative opiate use independently predicts narcotic consumption and complications after total joint arthroplasty. J Arthroplasty 2017 Sep;32(9):2658-62. DOI:
 40. Ben-Ari A, Chansky H, Rozet I. Preoperative opioid use is associated with early revision after total knee arthroplasty: A study of male patients treated in the Veterans Affairs system. J Bone Joint Surg Am 2017 Jan 4;99(1):1-9. DOI:
 41. Alam A, Juurlink DN. The prescription opioid epidemic: An overview for anesthesiologists. Can J Anaesth 2016 Jan;63(1):61-8. DOI:
 42. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Patients. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009 Aug;57(8):1331-4. DOI: https://doi/org/10.111/j.1532-5415.2009.02376.x.
 43. Volkow ND, McLellan AT. Opioid abuse in chronic pain—misconceptions and mitigation strategies. N Engl J Med 2016 Mar 31;374(13):1253-63. DOI:

Keywords: knee osteoarthritis, multimodal approach, opioid crisis, pain management, total joint arthroplasty, TJA

etoc emailClick here to join the eTOC list or text TPJ to 22828. You will receive an Email notice with the Table of Contents of each issue.

The Permanente Journal advances knowledge in scientific research, clinical medicine and innovative health care delivery. It is a peer-reviewed journal of medical science, social science in medicine, and medical humanities.

The Permanente Press

The Permanente Press publishes The Permanente Journal and books related to health care. For information about subscriptions, missing issues, billing, subscription renewal, and back issues, Email:


27,000 print readers per quarter, 15,350 eTOC readers, and in 2018, 2 million page views of TPJ articles in PubMed from a broad international readership.


The Kaiser Permanente National CME Program designates this journal-based CME activity for 4 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ISSN 1552-5767 Copyright © 2019

All Rights Reserved.